QAFHLXYVDRSYKL-AFDCHOCNSA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | Hdj8bsn63cg |
|---|---|
| InChI | InChI=1S/C24H50O6Si/c1-17(15-29-22(26)23(3,4)5)13-19(27-9)21(25)20(28-10)14-18(2)16-30-31(11,12)24(6,7)8/h17-21,25H,13-16H2,1-12H3/t17-,18-,19+,20+,21-/m0/s1 |
| InChIKey | QAFHLXYVDRSYKL-AFDCHOCNSA-N |
| Mol Weight | 462.7 g/mol |
| Molecular Formula | C24H50O6Si |
| Exact Mass | 462.337666 g/mol |
| Enantiomer InChIKey | QAFHLXYVDRSYKL-CRSSMBPESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
L-glycero-L-talo-Nonose, 2,3,7,8-tetradeoxy-2,8-dimethyl-4,6-di-O-methyl-, 1,3-propanediyl mercaptal
(+/-)-(1S*,3S*,5R*)-ETHYL-3-(TERT.-BUTYLDIMETHYLSILYLOXY)-METHYL-5-HYDROXY-CYCLOHEXYL-CARBOXYLATE
(+/-)-(1S*,3S*,5S*)-ETHYL-3-(TERT.-BUTYLDIMETHYLSILYLOXY)-METHYL-5-HYDROXY-CYCLOHEXYL-CARBOXYLATE
(1S,2R,4S,6R)-2,4-dibenzoxy-6-methoxy-cyclohexanol
(1R,3R,5R)-1-Acetoxy-3-tert-butylcarbonyloxy-5-(tert-butyldimethylsilyloxy)cyclohexane
(+/-)-7-BETA-[2-[(TERT.-BUTYLDIMETHYLSILYL)-OXY]-1-ALPHA-METHYLETHYL]-4-BETA-METHYL-2-CYCLOHEPTEN-1-BETA-OL
(1R,3R,5R)-1-Hydroxy-3-tert-butylcarbonyloxy-5-(tert-butyldimethylsilyloxy)cyclohexane
(S)-3-((2R,4R,6S)-6-Allyl-4-((tert-butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)-2-methylpropan-1-ol
(1S,2S,4S)-5-TERT.-BUTYLDIMETHYLSILYLOXY-2,4-DIMETHYL-1-HYDROXY-1-PHENYL-3-PENTANONE
D-Mannitol, 2,5-bis-O-(phenylmethyl)-, 1,6-bis(2,2-dimethylpropanoate)
| Title | Journal or Book | Year |
|---|---|---|
| Chemistry of tricarbonyl hemiketals and application of Evans technology to the total synthesis of the immunosuppressant (-)-FK-506 | Journal of the American Chemical Society | 1990 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.